From Cabozantinib to Zanzalintinib: Chemical Tweaks Open New Frontier in Product Hopping
For decades, the pharmaceutical industry’s most familiar strategy for extending the commercial life of a successful medicine has been to ...
Tag: resistance to cancer treatments
Hydralazine and ATRA Target Breast Cancer Cells
A groundbreaking study has unveiled the promising therapeutic potential of combining hydralazine, a well-known antihypertensive agent, with all-trans retinoic acid ...
ENTR1 Drives Colon Cancer via Glycolysis
In a groundbreaking advance in cancer research, scientists have unveiled the pivotal role of ENTR1, an endosome-associated trafficking regulator, in ...
New Study Unveils Navtemadlin’s Role in Glioblastoma, Suggesting Enhanced Treatment Opportunities
In an intriguing development within the realm of oncology, recent research conducted by scientists from the Dana-Farber Cancer Institute has ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!